Oral anti-Xa anticoagulation after trans-aortic valve implantation for aortic stenosis : The randomized ATLANTIS trial

Publié dans American Heart Journal 2018 June;200:40-50 Auteurs : Collet JP, Berti S, Cequier A, Van Belle E, Lefevre T, Leprince P, Neumann FJ, Vicaut E, Montalescot G. Article disponible en consultant le site Abstract Background and aim : Antithrombotic treatment regimen following transcatheter aortic valve replacement (TAVR) is not evidence-based. Apixaban, a non-vitamin K…

The times they are a changin’

Publié dans European Heart journal 2018 May; 39(19):1736-1739 Auteurs : Hammoudi N, Montalescot G Article disponible en consultant le site Abstract This editorial refers to "Safety and efficacy of dual vs. triple antithrombotic therapy in patients with atrial fibrillation following percutaneous coronary intervention: a systematic review and meta-analysis of randomized clinical trials" (link), by H.B.…

Cardiac manifestations in sickle cell disease varies with patient genotype

Publié dans British Journal of Haematology 2018 Apr Auteurs : Guedeney P, Lionnet F, Ceccaldi A, Stankovic Stojanovic K, Cohen A, Mattioni S, Montalescot G, Bachmeyer C, Isnard R, Haymann JP, Hammoudi N Article disponible en consultant le site Abstract Cardiac involvement is well characterized in sickle cell anaemia (SCA) but cardiac features associated with…